ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression

Sui, Shiyao; Xu, Shouping*; Pang, Da*哈尔滨医科大学
Pharmacology and Therapeutics2022-4DOI: 10.1016/j.pharmthera.2021.107992
51被引7阅读
引用收藏
分享

摘要

Breast cancer has become a serious threat to women's health. Cancer progression is mainly derived from resistance to apoptosis induced by procedures or therapies. Therefore, new drugs or models that can overcome apoptosis resistance should be identified. Ferroptosis is a recently identified mode of cell death characterized by excess reactive oxygen species-induced lipid peroxidation. Since ferroptosis is distinct from apoptosis, necrosis and autophagy, its induction successfully eliminates cancer cells that are resistant to other modes of cell death. Therefore, ferroptosis may become a new direction around which to design breast cancer treatment. Unfortunately, the complete appearance of ferroptosis in breast cancer has not yet been fully elucidated. Furthermore, whether ferroptosis inducers can be used in combination with traditional anti- breast cancer drugs is still unknown. Moreover, a summary of ferroptosis in breast cancer progression and therapy is currently not available. In this review, we discuss the roles of ferroptosis-associated modulators glutathione, glutathione peroxidase 4, iron, nuclear factor erythroid-2 related factor-2, superoxide dismutases, lipoxygenase and coenzyme Q in breast cancer. Furthermore, we provide evidence that traditional drugs against breast cancer induce ferroptosis, and that ferroptosis inducers eliminate breast cancer cells. Finally, we put forward prospect of using ferroptosis inducers in breast cancer therapy, and predict possible obstacles and corresponding solutions. This review will deepen our understanding of the relationship between ferroptosis and breast cancer, and provide new insights into breast cancer-related therapeutic strategies.

学科与关键词

关键词
FerroptosisBreast cancerGlutathioneGlutathione peroxidase 4IronNuclear factor erythroid-2 related factor-2Superoxide dismutasesLipoxygenaseCoenzyme Q
相关
加载中…
  • Ferroptosis: The Silver Lining of Cancer Therapy
    Tang, Zhengming; Huang, Zhijie; Huang, Yisheng; Chen, Yuanxin; Huang, Mingshu; Liu, Hongyu; Ye, Q. Adam*; Zhao, Jianjiang*; Jia, Bo*Frontiers in Cell and Developmental Biology, 2021, 9: 765859.被引 27
  • Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
    Shi, Tong-Mei; Chen, Xiao-Fei*; Ti, Huihui*Journal of Medicinal Chemistry, 2024, 67(4): 2238-2263.
  • Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
    Wang, Yaru; Sun, Yue; Wang, Feiran; Wang, Hongyi; Hu, Jing*Biomedicine and Pharmacotherapy, 2023, 169: 115866.
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmacology and Therapeutics
发表日期
2022-04
卷期
第 232 卷
页码
107992
DOI
10.1016/j.pharmthera.2021.107992
语言
ENGLISH
成果收录
SCIE
资助标注
ProjectNn10 ofHarbin Medical University Cancer Hospital [Nn102017-02]; National Natural Science Foundation of China [81602323, 81872149]; Outstanding Youth Project of Heilongjiang Provincial Natural Science Foundation [YQ2019H027]; Distinguished Young Scholars of Harbin Medical University Cancer Hospital [JCQN2018-03]; Yong Elite Training Foundation Grant of Harbin Medical University Cancer Hospital [JY2016-02]; Heilongjiang Postdoctoral Fund [LBH-Z20080]; China Postdoctoral Science Foundation [2021M693827]; Outstanding Project ofHaiyan Fund of HarbinMedical University Cancer Hospital [JJZD2021-12]; Innovation Fund of Harbin Medical University [2020-kyywf-1467]

作者

  • S

    Sui, Shiyao (第一作者)

    harbin med univ

  • X

    Xu, Shouping (通讯)

    harbin med univ

查看全部 3 位作者收起作者
  • P

    Pang, Da (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417